Repository logo
 
Loading...
Profile Picture
Person

Moreira, Ana Sofia

Search Results

Now showing 1 - 1 of 1
  • ESR Essentials: using the right scoring system in prostate MRI-practice recommendations by ESUR
    Publication . Ponsiglione, Andrea; Brembilla, Giorgio; Cuocolo, Renato; Gutierrez, Patricia; Moreira, Ana Sofia; Pecoraro, Martina; Zawaideh, Jeries; Barentsz, Jelle; Giganti, Francesco; Padhani, Anwar R; Panebianco, Valeria; Puech, Philippe; Villeirs, Geert
    MRI has gained prominence in the diagnostic workup of prostate cancer (PCa) patients, with the Prostate Imaging Reporting and Data System (PI-RADS) being widely used for cancer detection. Beyond PI-RADS, other MRI-based scoring tools have emerged to address broader aspects within the PCa domain. However, the multitude of available MRI-based grading systems has led to inconsistencies in their application within clinical workflows. The Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) assesses the likelihood of clinically significant radiological changes of PCa during active surveillance, and the Prostate Imaging for Local Recurrence Reporting (PI-RR) scoring system evaluates the risk of local recurrence after whole-gland therapies with curative intent. Underlying any system is the requirement to assess image quality using the Prostate Imaging Quality Scoring System (PI-QUAL). This article offers practicing radiologists a comprehensive overview of currently available scoring systems with clinical evidence supporting their use for managing PCa patients to enhance consistency in interpretation and facilitate effective communication with referring clinicians. KEY POINTS: Assessing image quality is essential for all prostate MRI interpretations and the PI-QUAL score represents  the standardized tool for this purpose. Current urological clinical guidelines for prostate cancer diagnosis and localization recommend adhering to the PI-RADS recommendations. The PRECISE and PI-RR scoring systems can be used for assessing radiological changes of prostate cancer during active surveillance and the likelihood of local recurrence after radical treatments respectively.